Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) shares reached a new 52-week low during trading on Monday . The ...

Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have been given a consensus recommendation of “Buy” by the ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA – Research Report), ...

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel ...

Dec. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. ("Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel ...

MENLO PARK, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the ...

Let's take a closer look to see what the different types of shareholders can tell us about Oruka Therapeutics. Institutions typically measure themselves against a benchmark when reporting to their ...

Dec. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Oruka Therapeutics, Inc. - 8-K, Current Report 14.11. Oruka Therapeutics files to sell 8.72M shares of common stock for holders 14.11. Oruka Therapeutics, Inc. - S-1, General form for registration ...